Thanks to a new technology, the diagnosis of brain cancer undergoes a breakthrough. The credit goes to cancer diagnostics company and University of Strathclyde Dxcover spin-out company. The company has indeed launched the liquid biopsy Dxcover, which was also effective in the early days of cancer growth, at a smaller volume and earlier stage.
q
There Research was published in the scientific journal Cancers.
Brain cancer: here are the advantages of the Dxcover liquid biopsy
According to Cancer Research UK, a 12,000 people in Britain are diagnosed with brain cancer each year and survival rates are 12% five years after diagnosis.
Read Also
- The City of Paris is considering a complaint for defamation against Gabriel Attal Nov 23, 2022
- Transport A container that fell off a truck ride closed the lane for hours in Hietalahdenranta, Helsinki Jul 3, 2021
- Tesla humanoid robot: probable launch in 2022 Aug 25, 2021
- Facebook and Google have criticized the decree trump about censorship in social networks May 29, 2020
- Listen to TV, Urbano Cairo blinds Giletti: renewal with LA7. The details Sep 3, 2021
- Two priests kidnapped in an attack on a church in northern Nigeria May 25, 2022
- Strike on Twitch: Ibai Llanos joined the streamers’ claim against harassment Sep 2, 2021